Intravenous iron in digestive diseases

Transfusion Alternatives in Transfusion Medicine

Volumn 12, Issue 3-4, 2012, Pages 122-129

  Gomollón, Fernando ^a   Gisbert, Javier P ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Anemia; Colon cancer; Digestive disease; Inflammatory bowel disease; Iron deficiency; Iron therapy

Indexed keywords

ANTITHROMBOCYTIC AGENT; DEXTRAN; FERRIC CARBOXYMALTOSE; FERRIC HYDROXIDE SUCROSE; FERROUS FUMARATE; FERROUS SULFATE; IRON; IRON DERIVATIVE; IRON DEXTRAN; IRON ISOMALTOSIDE; IRON SALT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANEMIA; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CANCER PATIENT; CLINICAL PRACTICE; CONGENITAL BLOOD VESSEL MALFORMATION; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM CANCER; DRUG EFFICACY; DRUG FORMULATION; DRUG STABILITY; DRUG SYNTHESIS; FOLLOW UP; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HIGH RISK POPULATION; HUMAN; INFLAMMATION; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRRITABLE COLON; MALABSORPTION; NEOPLASM; PRACTICE GUIDELINE; PRIORITY JOURNAL; SINGLE DRUG DOSE;

EID: 84866456172     PISSN: 12959022     EISSN: 1778428X     Source Type: Journal    
DOI: 10.1111/j.1778-428X.2012.01170.x     Document Type: Article

References (54)

1. Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011; 54: 328-43.
2. Balarajan Y, Ramakrishnan U, Ozaltin E, Shankar AH, Subramanian SV. Anaemia in low-income and middle-income countries. Lancet 2011; 378: 2123-35.
3. Lozoff B, Jimenez E, Smith JB. Double burden of iron deficiency in infancy and low socioeconomic status: a longitudinal analysis of cognitive test scores to age 19 years. Arch Pediatr Adolesc Med 2006; 160: 1108-13.
4. Muñoz M, Villar I, García-Erce JA. An update on iron physiology. World J Gastroenterol 2009; 15: 4617-26.
5. Moreno Chulilla JA, Romero-Colás MS, Gutiérrez Martín M. Classification of anemia for gastroenterologists. World J Gastroenterol 2009; 15: 4627-37.
6. Mearin F, Balboa A, Castells A, etal. [Iron deficiency anemia and use of intravenous iron in digestive disease]. Gastroenterol Hepatol 2010; 33: 605-13.
7. Gomollón F, Gisbert JP. Anemia and inflammatory bowel diseases. World J Gastroenterol 2009; 15: 4659-65.
8. Goddard AF, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anaemia. British Society of Gastroenterology. Gut 2000; 46(Suppl. 3-4): IV1-IV5.
9. Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006; 24: 1507-23.
10. Werner T, Wagner SJ, Martínez I, etal. Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis. Gut 2011; 60: 325-33.
11. Kaye P, Abdulla K, Wood J, etal. Iron-induced mucosal pathology of the upper gastrointestinal tract: a common finding in patients on oral iron therapy. Histopathology 2008; 53: 311-17.
12. Johnson-Wimbley TD, Graham DY. Diagnosis and management of iron deficiency anemia in the 21st century. Ther Adv Gastroenterol 2011; 4: 177-84.
13. Rimon E, Kagansky N, Kagansky M, etal. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med 2005; 118: 1142-7.
14. Hillman RS, Henderson PA. Control of marrow production by the level of iron supply. J Clin Invest 1969; 48: 454-60.
15. Ganz T. Hepcidin and iron regulation, 10 years later. Blood 2011; 117: 4425-33.
16. Ramsey AS. Intravenous iron in the treatment of anaemia. Br Med J 1950; 1: 1109-12.
17. Auerbach M, Coyne D, Ballard H. Intravenous iron: from anathema to standard of care. Am J Hematol 2008; 83: 580-8.
18. Gisbert JP, Gomollón F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol 2008; 103: 1299-307.
19. Goodhand JR, Kamperidis N, Rao A, etal. Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease. Inflamm Bowel Dis 2012; 18: 513-19.
20. Gregory K, Halliday M, Averill C, etal. Iron deficiency anaemia: further education regarding the British Society of Gastroenterology guidelines is required. Gut 2007; 56: 1319.
21. Fernández-Bañares F, Monzón H, Forné M. A short review of malabsorption and anemia. World J Gastroenterol 2009; 15: 4644-52.
22. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-23.
23. Theurl I, Aigner E, Theurl M, etal. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 2009; 113: 5277-86.
24. Semrin G, Fishman DS, Bousvaros A, etal. Impaired iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis 2006; 12: 1101-6.
25. Weiss G, Gasche C. Pathogenesis and treatment of anemia in inflammatory bowel disease. Haematologica 2010; 95: 175-8.
26. Stein J, Hartmann F, Dignass A. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol 2010; 7: 599-610.
27. Muñoz M, Gómez-Ramírez S, García-Erce JA. Intravenous iron in inflammatory bowel disease. World J Gastroenterol 2009; 15: 4666-74.
28. Kell DB. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics 2009; 2: 2.
29. Kell DB. Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples. Arch Toxicol 2010; 84: 825-89.
30. Lindgren S, Wikman O, Befrits R, etal. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 2009; 44: 838-45.
31. Lyseng-Williamson KA, Keating GM. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. Drugs 2009; 69: 739-56.
32. Kulnigg S, Stoinov S, Simanenkov V, etal. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 2008; 103: 1182-92.
33. Gisbert JP, Bermejo F, Pajares R, etal. Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement. Inflamm Bowel Dis 2010; 15: 1485-91.
34. Kulnigg S, Teischinger L, Dejaco C, Waldhör T, Gasche C. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment. Am J Gastroenterol 2009; 104: 1460-7.
35. Evstatiev R, Marteau P, Iqbal T, etal. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology 2011; 141: 846-53.
36. Porter ME. A strategy for health-care reform - toward a value-based system. N Engl J Med 2009; 361: 109-12.
37. Knight K, Wade S, Balducci L. Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med 2004; 116(Suppl. 7A): 11S-26S.
38. Jensen LS, Puho E, Pedersen L, Mortensen FV, Sørensen HT. Long-term survival after colorectal surgery associated with buffy-coat-poor and leucocyte-depleted blood transfusion: a follow-up study. Lancet 2005; 365: 681-2.
39. Muñoz M, Campos A, García-Erce JA. Intravenous iron in colorectal cancer surgery. Semin Hematol 2006; 43: S36-S38.
40. Muñoz M, García-Erce JA, Díez-Lobo AI, etal. [Usefulness of the administration of intravenous iron sucrose for the correction of preoperative anemia in major surgery patients]. Med Clin (Barc) 2009; 132: 303-6.
41. Edwards TJ, Noble EJ, Durran A, Mellor N, Hosie KB. Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients alter colorectal cancer surgery. Br J Surg 2009; 96: 1122-8.
42. Lanas A, García-Rodríguez LA, Polo-Tomás M, etal. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol 2009; 104: 1633-41.
43. Sostres C, Gargallo C, Lanas A. Drug-related damage of the ageing gastrointestinal tract. Best Pract Res Clin Gastroenterol 2009; 23: 849-60.
44. García-Erce JA, Gomollón F, Muñoz M. Blood transfusion for the treatment of acute anemia in inflammatory bowel disease and other digestive diseases. World J Gastroenterol 2009; 15: 4686-94.
45. Marchetti A, Parker MS, Moccia LP, etal. Ferritin is used for iron storage in bloom-forming marine pennate diatoms. Nature 2009; 457: 467-70.
46. Chertow GM, Mason PD, Vaage-Nielsen O, Ahlmén J. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 2006; 21: 378-82.
47. Toblli JE, Cao G, Olivieri L, Angerosa M. Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds. Nephrol Dial Transplant 2010; 25: 3631-40.
48. Phrommintikul A, Haas SJ, Elsik M, Krum H. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 2007; 369: 381-8.
49. Singh AK. Resolved: targeting a higher hemoglobin is associated with greater risk in patients with CKD anemia: pro. J Am Soc Nephrol 2009; 20: 1436-41.
50. Bermejo F, García-López S. A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases. World J Gastroenterol 2009; 15: 4638-43.
51. Auerbach M, Goodnough LT, Picard D, Maniatis A. The role of intravenous iron in anemia management and transfusion avoidance. Transfusion 2008; 48: 988-1000.
52. Bhandari S. A hospital-based cost minimization study of the potential financial impact on the UK health care system of introduction of iron isomaltoside 1000. Ther Clin Risk Manag 2011; 7: 103-13.
53. Goddard AF, James MW, McIntyre AS, Scott BB. British Society of Gastroenterology. Guidelines for the management of iron deficiency anaemia. Gut 2011; 60: 1309-16.
54. Gasche C, Berstad A, Befrits R, etal. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007; 13: 1545-53.